Travere

Travere Therapeutics Reports First Quarter 2026 Financial Results

Travere Therapeutics Announces Q1 2026 Financial Results Travere Therapeutics, Inc. reported a strong start to 2026, marked by significant commercial growth, regulatory milestones, and continued advancement across its pipeline programs. The company’s first-quarter performance reflects increasing demand for its lead…

Read MoreTravere Therapeutics Reports First Quarter 2026 Financial Results
Evolus

Evolus Reports Q1 2026 Results; Posts Second Straight Positive Adjusted EBITDA and Reaffirms Outlook

Revenue grows 7% year over year to $73.1 million as the company advances toward full-year profitability and sustained double-digit growth Evolus, reported strong financial and operational performance for the first quarter of 2026, marking a notable continuation of its profitability…

Read MoreEvolus Reports Q1 2026 Results; Posts Second Straight Positive Adjusted EBITDA and Reaffirms Outlook
Anthem

Anthem Blue Cross and Blue Shield Helps Georgia Small Businesses Cut Costs and Improve Health

Anthem Blue Cross and Blue Shield Supports Georgia Small Businesses in Reducing Costs and Enhancing Health Outcomes As healthcare costs continue to climb across the United States, small businesses in Georgia are facing increasing pressure to provide quality employee benefits…

Read MoreAnthem Blue Cross and Blue Shield Helps Georgia Small Businesses Cut Costs and Improve Health
Leon

Leon Medical Centers Shows Strong Results from PERS & Fall Detection Program with MedSys Health

Leon Medical Centers Demonstrates Strong Clinical and Operational Impact Through Advanced Fall Detection and PERS Program in Collaboration with MedSys Health Leon Medical Centers, a prominent healthcare services organization dedicated to serving Medicare patients across South Florida, has reported highly…

Read MoreLeon Medical Centers Shows Strong Results from PERS & Fall Detection Program with MedSys Health